Introduction: Randomized trials in obstructive coronary artery disease (CAD) have largely
shown no prognostic benefit from revascularization. While there are several potential …

BACKGROUND: Randomized trials in obstructive coronary artery disease (CAD) have
largely shown no prognostic benefit from coronary revascularization. Although there are …

BACKGROUND: Ischemic and non-ischemic cardiomyopathy (ICM and NICM) both cause
heart failure, but the different etiologies may result in differences in management and …

Background: Atherosclerosis is associated with a worse prognosis in many diseases such
as ischemic cardiomyopathy, but its impact in non-ischemic dilated cardiomyopathy (dCMP) …

Background Owing to its variable course from asymptomatic cases to sudden death risk
stratification is of paramount importance in newly diagnosed non-ischemic cardiomyopathy …

Background LGE by CMR is a predictor of adverse cardiovascular outcomes in non-
ischemic cardiomyopathy (NICM) patients. However, these findings are limited by single …

BACKGROUND: Definition of ischemic cardiomyopathy (IC) is not always obvious, which is
why new criteria based on prognosis and the extent of the coronary artery disease (CAD) …

Aims To characterize the phenotype, clinical outcomes and rate of disease progression in
patients with early‐stage non‐ischaemic cardiomyopathy (early‐NICM). Methods and results …

Background—Late gadolinium enhancement (LGE) by cardiac MR (CMR) is a predictor of
adverse cardiovascular outcomes in patients with nonischemic cardiomyopathy (NICM) …

The term ''cardiomyopathy''refers to specific diseases affecting the myocardium which
generally lead to clinical manifestations of heart failure, including exercise intolerance …